Squarepoint’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Squarepoint’s Portfolio THRX Stock Details THRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-41,708	Closed	-$169K	–	4783
2023 Q4	$169K	Buy	41,708 +22,055	+112%	+$67.3K	﹤0.01%	3655
2023 Q3	$52.9K	Buy	+19,653	New	+$77K	﹤0.01%	3631

Squarepoint's THRX Position: Q1 2024 in Review

Squarepoint sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 41,708 shares — an estimated $169K sold.

Squarepoint first reported a position in THRX in Q3 2023 and held it in 2 quarters. The position peaked at $169K in Q4 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

Squarepoint reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Squarepoint sold 41,708 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $169K.
Squarepoint first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Squarepoint's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $169K in Q4 2023.
1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Squarepoint's 13F filing for Q1 2024, filed 15 May 2024.